- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ovarian cancer, pembrolizumab, olaparib
Total 5972 results
-
SandozCompleted
-
Anhui Provincial Cancer HospitalHutchison Medipharma LimitedRecruiting
-
Vall d'Hebron Institute of OncologyRecruiting
-
AstraZenecaRecruitingUsing NCID Database to Assess the Safety of Olaparib in Chinese Patients With Ovarian Cancer by Examining the Incidence, Seriousness, and Severity of All AEChina
-
Mario Negri Institute for Pharmacological ResearchAstraZenecaRecruitingCarcinoma, Ovarian EpithelialItaly
-
Alexander B Olawaiye, MDAstraZenecaRecruiting
-
University of Alabama at BirminghamMerck Sharp & Dohme LLCNot yet recruitingOvarian CancerUnited States
-
University Medical Center GroningenNot yet recruitingRenal Cell Carcinoma | Breast Carcinoma | Thyroid Carcinoma | Ovarian Carcinoma | Endometrium CarcinomaNetherlands
-
ExelixisRecruitingAdvanced Solid TumorUnited States
-
University of Colorado, DenverImmunoGen, Inc.RecruitingFallopian Tube Cancer | Peritoneal Cancer | Ovary CancerUnited States
-
OnxeoRecruitingBreast Cancer | Metastatic Castration-resistant Prostate Cancer | Recurrent Epithelial Ovarian CancerUnited States
-
National Cancer Institute (NCI)RecruitingAnatomic Stage III Breast Cancer AJCC v8 | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Locally Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid... and other conditionsUnited States, Puerto Rico
-
National Cancer Institute (NCI)NRG OncologyRecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Endometrial CarcinomaUnited States, Puerto Rico
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingOvarian Neoplasms
-
Sunnybrook Health Sciences CentreCentre hospitalier de l'Université de Montréal (CHUM); Exactis Innovation; Princess...RecruitingOvarian Cancer | Triple Negative Breast Cancer | High Grade Serous CarcinomaCanada
-
National Cancer Institute, NaplesRecruiting
-
Nuvation Bio Inc.RecruitingBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Breast Carcinoma | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | Advanced Solid Tumor | Cancer of the Ovary | Pancreas Cancer | Triple-negative Breast Cancer | Cancer of Pancreas | Pancreas Neoplasm | Prostate Neoplasm | Cancer... and other conditionsUnited States, Australia
-
National Cancer Institute, NaplesRecruiting
-
Kosei Hasegawa, MD, PhDRecruitingCarcinoma, Ovarian EpithelialJapan
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruiting
-
Poznan University of Medical SciencesPoznan University Hospital of Lord's TransfigurationRecruiting
-
AstraZenecaRecruitingOvarian CancerChina, Vietnam, Russian Federation, Ukraine, South Africa, Turkey, India, Peru, Colombia, Poland, Chile, Philippines
-
Gustave Roussy, Cancer Campus, Grand ParisRecruiting
-
Leiden University Medical CenterUniversity Medical Center Groningen; Erasmus Medical CenterRecruitingBRCA1 Mutation | BRCA2 Mutation | Homologous Recombination Deficiency | Ovarian Neoplasm EpithelialNetherlands
-
Nordic Society of Gynaecological Oncology - Clinical...Hellenic Cooperative Oncology Group; European Network of Gynaecological Oncological... and other collaboratorsRecruiting
-
AGO Research GmbHRecruitingEpithelial Ovarian CancerGermany
-
National Cancer Institute (NCI)RecruitingRecurrent Ovarian High Grade Serous Adenocarcinoma | Recurrent Platinum-Resistant Ovarian CarcinomaUnited States
-
Xiaoxiang ChenRecruitingNeoplasms | Neoplasms by Histologic Type | Urogenital Neoplasms | Neoplasms by Site | Carcinoma | Neoplasms, Glandular and Epithelial | Genital Neoplasms, Female | Ovarian Diseases | Adnexal Diseases | Carcinoma, Ovarian Epithelial | Ovarian Cancer | Angiogenesis | Genital Diseases, Female | Antineoplastic Agents | BRCA1... and other conditionsChina
-
AstraZenecaRecruitingOvarian Cancer | Prostate CancerChina
-
AstraZenecaRecruitingBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate CancerKorea, Republic of
-
National Cancer Institute, NaplesRecruitingBRCA Wild Type Platinum Sensitive Recurrent Ovarian CancerItaly
-
Institute of Cancer Research, United KingdomAstraZeneca; Cancer Research UKRecruitingGynaecological CancersUnited Kingdom
-
Yonsei UniversitySamsung Medical Center; AstraZeneca; Seoul National University Hospital; Korean... and other collaboratorsRecruitingPlatinum-resistant Recurrent Ovarian CancerKorea, Republic of
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
University of PennsylvaniaAstraZeneca; Myriad Genetics, Inc.RecruitingHigh Grade Serous CarcinomaUnited States
-
University College, LondonRecruitingOvarian CancerAustralia, United Kingdom, Canada, New Zealand
-
National Cancer Institute (NCI)RecruitingBreast Neoplasms | Colorectal NeoplasmsUnited States
-
AstraZenecaRecruitingAdv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian CancerSpain, United States, Belgium, United Kingdom, France, Hungary, Canada, Korea, Republic of, Australia
-
Hoffmann-La RocheGOG Foundation; European Network of Gynaecological Oncological Trial Groups...Active, not recruitingOvarian CancerUnited States, Korea, Republic of, France, Germany, Spain, Italy, Canada, Russian Federation, United Kingdom, Turkey, Australia, Czechia, Switzerland
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingEndometrial Mixed Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Stage IV Uterine Corpus Cancer AJCC v8 | Endometrial Adenocarcinoma | Endometrioid AdenocarcinomaUnited States, Canada
-
Tango Therapeutics, Inc.TerminatedBreast Cancer | Ovarian Cancer | Prostate Cancer | Pancreas Cancer | BRCA1 Mutation | BRCA-Mutated Ovarian Carcinoma | BRCA-Associated Breast Carcinoma | HRD Positive Advanced Ovarian CancerUnited States
-
Novartis PharmaceuticalsActive, not recruitingOvarian CancerUnited States, Italy, United Kingdom, Malaysia, Taiwan, Turkey, Belgium, Canada, Spain, Singapore, Austria, Denmark, Korea, Republic of, Australia, China, France, Netherlands, Russian Federation, Germany, Argentina, Mexico, Finland, Portuga... and more
-
AstraZenecaMerck Sharp & Dohme LLC; GOG Foundation; Myriad Genetic Laboratories, Inc.Active, not recruitingAdvanced Ovarian Cancer | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete Response | BRCA Mutation | First Line Platinum ChemotherapyKorea, Republic of, France, Italy, United States, Israel, Canada, China, Brazil, United Kingdom, Poland, Australia, Japan, Netherlands, Russian Federation, Spain
-
AstraZenecaEnrolling by invitationBreast Cancer | Ovarian CancerItaly, Spain, United States, Canada, Belgium, Denmark, Korea, Republic of, Czechia, Turkey, China, United Kingdom, Taiwan, Brazil, Israel, France, Hungary, Poland, Portugal, Germany, Russian Federation, Bulgaria, Finland, Slovenia, Sw...
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Carcinoma | Metastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Metastatic Melanoma | Fallopian Tube Carcinoma | Advanced Malignant Solid Neoplasm | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage III Renal... and other conditionsUnited States
-
National Cancer Institute (NCI)NRG Oncology; Canadian Cancer Trials GroupActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian... and other conditionsUnited States, Canada, Puerto Rico, Korea, Republic of, Japan
-
National Cancer Institute (NCI)AstraZeneca; NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Fallopian... and other conditionsUnited States, Canada, Korea, Republic of, Japan
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Primary Peritoneal Carcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Malignant Ovarian Endometrioid Tumor | Ovarian High Grade Serous Adenocarcinoma | Platinum-Sensitive Ovarian Carcinoma | Fallopian Tube High Grade Serous Adenocarcinoma and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Endometrial Adenocarcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast... and other conditionsUnited States
-
AstraZenecaActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum SensitiveChina, Malaysia